Company CHO Pharma, Inc.

6586

TW0006586001

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Biopharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
55.2 ^TWD	-0.36%		+0.91%	-20.35%

Mar. 20	CHO Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	CHO Pharma, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

CHO PHARMA INC. is principally engaged in the development of new drugs related to sugar molecules. The companyâs technology and development can be divided into eight categories according to its patent features, including homogeneous antibody drugs, monoclonal antibodies of cancers and immune-related diseases, carbohydrate-related vaccines and drugs, anti-influenza drugs, the development and application of Saccharin tablets, the development and application of sugar probes, the synthesis identification development and application of sugar molecular, as well as the derivative patents of innovation development plans.

Managers	Title	Age	Since
Tsung I Wu CEO	Chief Executive Officer	-	-
Chao-Long Chen CHM	Chairman	-	17-12-26
Yi Pei Chou DFI	Director of Finance/CFO	-	16-03-27

Members of the board	Title	Age	Since
Ming Hsing Tsai BRD	Director/Board Member	66	13-05-26
Hsuan Ta Liu BRD	Director/Board Member	-	19-06-05
Chao-Long Chen CHM	Chairman	-	17-12-26
Tsung Liang Chien BRD	Director/Board Member	-	16-11-20
Ying Hsin Tsai BRD	Director/Board Member	-	16-11-20
Ming Che Sih BRD	Director/Board Member	-	19-06-05
Chin Lieh Wu BRD	Director/Board Member	-	19-06-05

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	214,011,000	214,000,500 ( 100.00 %)	0	100.00 %

Name	Equities	%	Valuation
Academia Sinica 16.49 %	35,288,600	16.49 %	66 M NT$
Diamond BioFund Inc /Investment/ 15.17 %	32,473,491	15.17 %	60 M NT$
Tsung I Wu 2.836 %	6,069,800	2.836 %	11 M NT$
Ming Hsing Tsai 1.548 %	3,312,500	1.548 %	6 M NT$

CHO Pharma, Inc.

7/F, Building C 99 Lane 130, Yanjiu Road Section 1

115 71, Taipei

http://www.chopharma.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CHO PHARMA, INC.	-20.35%	362M
CSL LIMITED	-4.66%	86.13B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	39.82B
BIOGEN INC.	-19.27%	30.42B
UCB	+57.86%	25.23B
BIOMARIN PHARMACEUTICAL INC.	-16.09%	15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.95B
INCYTE CORPORATION	-17.69%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.51B
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	8.71B